Mirae Asset Global Investments announced on Nov. 24 that its U.S. ETF management subsidiary Global X listed three new covered call ETFs covering the financials, healthcare, and IT sectors of the S&P500 on the New York Stock Exchange on Nov. 22 (local time).The Global X Financials Covered Call & Grow
The Ministry of Trade, Industry and Energy released a supply chain diversification strategy at its meeting on Nov. 23, which was hosted by President Yoon Suk-yeol.The strategy is to reduce supply chain risks by relying less on China. The government is planning to assist in relocation of South Korean
The author is an analyst of NH Investment & Securities. He can be reached at junsup@nhqv.com. -- Ed. In 2022, there has been a mix of expectations and concerns for the insurance sector, as interest rates (the biggest variable for fundamentals) have jumped faster than expected and IFRS17 is set to be
Daewoong Pharmaceutical’s “SAY PAIN!” campaign nabbed the top prize in the international PR sector at KPRA Awards 2022 hosted by the Korea PR Association (KPRA) on Nov. 9.The “SAY PAIN!” campaign is a social contribution campaign spearheaded by Daewoong Pharmaceutical in Indonesia. It aims to contri
The Korea Institute of Machinery and Materials (KIMM) has developed a rapid, automated molecular diagnosis system integrated with a non-face-to-face specimen collection robot. The new system can collect specimens at the medical sites using a specimen collection robot in a non-face-to-face manner to
The author is an analyst of KB Securities. He can be reached at joonsop.analyst@kbfg.com. -- Ed. Maintain BUY, target price of KRW44,000 We maintain BUY and TP of KRW44,000 on KT. The company should maintain its upward trajectory through 2023, propelled by its non-telco DIGICO business and steady wi
The author is an analyst of KB Securities. He can be reached at kimtaehee@kbfg.com. -- Ed. Slightly lower target price to KRW350,000 on WACC increase We slightly lower our TP (KRW380,000→KRW350,000) on Hanmi Pharm. While we revise up our earnings estimates to reflect 3Q22 results, we raise RFR to 3.
Korea Forest Service Minister Nam Sung-hyun took office in May, declaring forest renaissance. The following is Business Korea’s recent interview with him. -- Ed.What is the concept of forest renaissance?The Korea Forest Service is making various efforts to advance forest management, which is to maxi
Celltrion Healthcare is in dispute with the U.K. government over a "penalizing rebate."The U.K. government introduced the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) in 2019, which requires pharmaceutical companies to pay a percentage of their net sales of certain products to th
EOFlow Co. announced on Oct. 25 that it has received certification from the Ministry of Health of Indonesia to commercialize its wearable insulin pump ‘EOPatch’ and its controller ‘ADM’. Its smartphone app ‘Narsha’ does not require an approval from the ministry.On December 2021, EOFlow announced tha
EOFlow Co., a provider of wearable drug delivery systems (DDS), announced on Oct. 24 that it would invest 36.9 billion won in its U.S. subsidiary EOFlow, Inc.The majority of this investment in EOFlow, Inc., approximately 31 billion won, will be used for collecting loans given by EOFlow to its U.S. s
SK bioscience announced on Oct 21 that it has hired Harry Kleanthous, senior program officer of the Bill & Melinda Gates Foundation, as vice president of vaccine R&D strategy and external innovation of SK bioscience USA, its U.S. subsidiary.Kleanthous has served as vice president of Acambis Inc., a
EOFlow Co., the producer of EOPatch, a small and light wearable insulin pump, has exported an EOPatch production line to its joint venture in China, Sinoflow Co., the company announced on Oct. 17.On Sept. 30, the company shipped equipment to set up an EOPatch production line in Sinoflow, along with
The author is an analyst of NH Investment & Securities. He can be reached at yongjin.seol@nhqv.com. -- Ed. Korean Re is likely to report sluggish earnings due to natural catastrophe losses. However, expectations for structural growth remain valid and the firm’s valuations are also attractive.Continu
The author is an analyst of NH Investment & Securities. He can be reached at esshim@nhqv.com. -- Ed. Founded in 2009, ViOL was listed on the Kosdaq in Nov 2020 through a merger with a SPAC. Specialized in beauty medical devices, the firm is expected to enjoy robust earnings growth going forward, tha
Busan City had a meeting on Oct. 11 in order to discuss how to support the BTS concert scheduled for Oct. 15. BTS will give the concert at the Busan Asiad Main Stadium to help the city become the venue of Expo 2030.At the meeting, the city conducted simulations related to traffic, safety, emergency
People Power Party lawmaker Lee Jong-seong remarked on Oct. 11 that the number of national health insurance subscribers who are dependents decreased from more than 20.06 million to 18.09 million from 2017 to 2021 and to 17,937,000 until July this year.“However, the number of foreign dependents incre
Model Solution, a subsidiary of Hankook & Company Group (formerly Hankook Tire Group), has become the first Korean prototype company to be listed on the KOSDAQ.Founded in 1993, Model Solution is a total solution provider that serves the entire product development stage from design to prototypes, pre
SK Group announced on Sept. 26 that it offered free surgery for Vietnamese children with facial deformities at 108 Military Central Hospital in Hanoi from Sept. 19 to 23, in cooperation with Seoul National University Bundang Hospital and Smile for Children, a Korean medical volunteer organization. T
The author is an analyst of NH Investment & Securities. She can be reached at jiyoony@nhqv.com. -- Ed. IB Kimyoung is to book stable earnings at the college transfer division thanks to: 1) an increase in the number of transfer slots at the police college and pharmacy and medical colleges for the 202